Bruciamacchie, M., Garambois, V., Vie, N., Bessede, T., Michaud, H., Chepeaux, L., . . . Jarlier, M. (2025). ATR inhibition potentiates FOLFIRINOX cytotoxic effect in models of pancreatic ductal adenocarcinoma by remodelling the tumour microenvironment: Translational Therapeutics. British Journal of Cancer, 132(2), 222. https://doi.org/10.1038/s41416-024-02904-3
Chicago Style (17th ed.) CitationBruciamacchie, Marine, et al. "ATR Inhibition Potentiates FOLFIRINOX Cytotoxic Effect in Models of Pancreatic Ductal Adenocarcinoma by Remodelling the Tumour Microenvironment: Translational Therapeutics." British Journal of Cancer 132, no. 2 (2025): 222. https://doi.org/10.1038/s41416-024-02904-3.
MLA (9th ed.) CitationBruciamacchie, Marine, et al. "ATR Inhibition Potentiates FOLFIRINOX Cytotoxic Effect in Models of Pancreatic Ductal Adenocarcinoma by Remodelling the Tumour Microenvironment: Translational Therapeutics." British Journal of Cancer, vol. 132, no. 2, 2025, p. 222, https://doi.org/10.1038/s41416-024-02904-3.